Background: One of the histone acetyltransferases (HATs) family of proteins, human MOF (hMOF, MYST1), is involved in histone H4 acetylation, particularly at lysine 16 (H4K16Ac), an epigenetic mark of active genes. Dysregulation of the epigenetic mark influences cellular biology and possibly leads to oncogenesis. We examined the involvement of hMOF and H4K16Ac in primary nonsmall cell lung cancer (NSCLC). Methods: Reverse transcription polymerase chain reaction using fresh-frozen lung cancer tissues and lung cancer cell lines and immunohistochemistry for hMOF and H4 K16Ac via tissue microarray of 551 formalin-fixed paraffin-embedded NSCLC tissue blocks were conducted. Results: hMOF mRNA was frequently overexpressed in lung cancer tissues, compared with normal lung tissues (10/20, 50%). NSCLC tissues were positive for hMOF in 37.6% (184/489) and H4K16Ac in 24.7% (122/493) of cases. hMOF protein expression was tightly correlated with the H4K16Ac level in tumors (p< 0.001). Knockdown of hMOF mRNA with siRNA led to a significant inhibition of growth in the Calu-6 cell line. Conclusions: hMOF was frequently expressed in NSCLC and was correlated with H4K16Ac. To our knowledge, this is the first study that has focused on the expression status of HATs and hMOF in NSCLC. Our results clearly suggest a potential oncogenic role of the gene and support its utility as a potential therapeutic target.
Chromatin nucleosomes are composed of genomic DNA wrap ped around an octamer of core histone proteins consisting of two copies of histones H2A, H2B, H3, and H4. 1 The N termi ni of histones H3 and H4 are subject to a variety of modifica tions, including acetylation, phosphorylation, methylation, ubi quitination, and ADP ribosylation. 24 Histone acetylation, one of the most extensively characterized epigenetic modifications, is controlled by histone acetyltransferases (HATs) and histone deacetylases (HDACs). 3 The histone H4 tail contains four close ly spaced lysines (K5, K8, K12, and K16) that are subjected to acetylation by various HATs. 5 Histone acetylation is generally regarded as an activating modification but also appears to play a role in gene repression, DNA repair, and DNA replication and recombination. 6, 7 In view of the involvement of histone acetyla tion in these fundamental processes, aberrant physiological acet ylation status has been implicated in human cancer. A mutation of p300 acetyltransferase, which acetylates lysine residues in his tone tails, has been reported in primary tumors and cell lines. 8 An analysis of global histone modifications, including acetylat ed lysines, has prognostic value for predicting the recurrence of prostate cancer after surgery. 9 HDACs display increased activity in cancer cells, 10 and HDAC inhibitors have been identified as promising antitumor agents in several clinical trials. 11 However, the particular enzymes and affected lysine residues responsible for tumorigenesis are yet to be established. Thus, identifying the enzymes that modify specific residues should aid in direct ing the search for potential drug targets.
Interestingly, about 60% of total histone H4 is monoacety lated, mainly at lysine 16, 12 in normal human cells, whereas this acetylation is frequently lost in cancer. 13 Mendjan et al. 14 and Smith et al. 15 recently purified the human MOF (hMOF) com plex. These groups showed that hMOF specifically acetylates histone 4 lysine 16 (H4K16) in mammalian cells, similar to its Drosophila ortholog, and its depletion leads to the global re duction of H4K16 acetylation in HeLa cells. 16 Additionally, hMOFdepleted cells show an impaired DNA repair response following ionizing radiation, 16 and hMOF is involved in ataxia telangiectasiamutated function. 17 More recently, hMOF has been shown to acetylate the tumor suppressor protein p53, in turn, influencing the behavior of p53 in response to DNA dam
The Histone Acetyltransferase hMOF is Overexpressed in Non-small Cell Lung Carcinoma age. 18 These data collectively suggest roles for hMOF in tran scriptional regulation, cell proliferation, differentiation, and the DNA repair response. 15, 16 Because hMOF is involved in these important cellular processes with obvious links to cancer, it is important to establish its expression patterns in tumors and as certain whether loss or gain of hMOF underlies the increased histone H4 acetylation, particularly at lysine 16 (H4K16Ac) level in tumors.
In this study, hMOF protein expression and H4K16 acetyla tion status were investigated via immunohistochemistry (IHC) on tissue microarrays (TMAs) of 551 primary nonsmall cell lung cancer (NSCLC) samples, and the hMOF mRNA levels were assessed in freshly frozen paired normal and cancer tissue and in cell lines. We also examined the knockdown effect of the gene in lung cancer cell lines using specific siRNA.
MATERIALS AND METHODS

Cell lines and tissue samples
Five NSCLC cell lines (A549, Calu6, NCIH358, EKVX, and NCIH460) were obtained from the American Type Cul ture Collection (Rockville, MD, USA) and cultivated in tissue culture flasks (Techno Plastic Products TPP, Trasadingen, Swit zerland) containing RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin (Gibco, Berlin, Germany).
hMOF mRNA levels were detected in 20 normal and tumor paired freshfrozen NSCLC tissue samples. Primary cell culture of three paired normal and freshfrozen cancer NSCLC tissue samples was additionally performed to validate the results ob tained with the NSCLC cell lines.
Case selection and TMA construction
In total, 551 cases of NSCLC resected between 2000 and 2003 were selected from the pathology files of Asan Medical Center, Seoul, Korea. Tumors were restaged according to the 7th edi tion of the American Joint Committee on Cancer staging sys tem. 19 Histological typing and grading were performed accord ing to World Health Organization guidelines. 20 Medical re cords, the database of the Department of Thoracic and Cardio vascular Surgery, Asan Medical Center, and telephone interviews were used to determine patient survival status. Survival times and outcome data were available for all 551 patients. The me dian followup period was 65.8 months. Recurrence of disease was assessed either by radiological or bronchoscopic examina tion and confirmed in some cases with biopsies or surgery. Two patterns of recurrence were defined; specifically, locoregional recurrence and distant metastasis to the liver, adrenal gland, con tralateral lung, brain, and bone marrow. Diseasefree survival was defined as the interval from the date of surgery to recurrence or last followup.
TMAs were constructed from paraffinembedded blocks of 551 NSCLC samples after review of the glass slides. Two different areas of the tumors were punched and reembedded into recipi ent blocks using a tissue array device (Beecher Instruments, Sun Prairie, WI, USA) with 1.5 mm cylinders, as described previ ously. 21 Each microarray block contained 68 NSCLC samples.
Total RNA isolation and cDNA synthesis
Total RNA was extracted from cell lines, primary cells, and lung tissue using the Qiagen RNA Extraction kit (Valencia, CA, USA), as directed by the manufacturer, and treated with DNAse I prior to reverse transcription.
Real time quantitative-polymerase chain reaction (RQ-PCR) assay RQPCR was conducted in an iCycler iQ RealTime PCR Detection System (BioRad, Hercules, CA, USA) using SYBR ® Green I as the detection dye. The quantity of hMOF transcripts in each sample was standardized to that of a housekeeping gene, β2microglobulin. hMOF was amplified with the primer pair, 5´TCGGAGAAACGTACCTGTGC3´ and 5´CCGGTTCTT GTCTACCCACT3´. β2microglobulin cDNA was amplified us ing the primer pair, 5´ACCCCCACTGAAAAAGATGA3´ and 5´ATCTTCAAACCTCCATGATG3´. For amplification, 5 µL of total (20 µL) cDNA solution was added to 13 µL of Taq premix (Toyobo, Osaka, Japan) and 2 µL (5 µM each) of prim ers. The PCR reaction was conducted following a fourstage re action setting: 1) 95˚C for 5 minutes, 2) 95˚C for 15 minutes, 3) 30 cycles at 94˚C for 15 seconds, 25 seconds for 60˚C and 72˚C, and 4) 72˚C for 7 minutes.
The threshold cycle (Ct; the cycle number at which the amount of amplified gene of interest reached a fixed threshold) was sub sequently determined. Relative quantitation of hMOF mRNA expression was performed with the comparative Ct method, as described previously. 22 The quantitation target value, normal ized to that of the endogenous control β2microglobulin (house keeping) gene and relative to a calibrator, was expressed as 2 ) were seeded in sixwell plates, and 500 pmol of the siRNA duplex was trans fected using the XtremeGENE siRNA Transfection Reagent (Roche Diagnostics, Indianapolis, IN, USA), according to the manufacturer's instructions. Cells were cultivated for 24, 48, and 72hours and then harvested.
Immunohistochemical staining and evaluation
TMA blocks were sectioned at a thickness of 4 µm and mount ed on precoated glass slides. Sections were deparaffinized using a series of xylene and rehydrated through graded alcohol to dis tilled water. Endogenous peroxidase was quenched with 3% hydrogen peroxide in methanol at room temperature (25.8˚C). Sections were placed in a 95˚C solution of 0.01 M sodium ci trate buffer, pH 6.0, for antigen retrieval. Normal goat serum (5%) was applied for 30 minutes to block nonspecific protein binding sites. Primary rabbit antihistone polyclonal antibodies were applied for 1hour at room temperature at the following dilutions: antiacetylhistone H4K16 (1 :1,000, H4K16Ac, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and pri mary mouse antihMOF monoclonal antibodies (1:200, Santa Cruz Biotechnology Inc.). Antibody binding was detected using the streptavidinbiotinperoxidase complex/HRP, Code K0377 (Dako, Carpinteria, CA, USA), with 3,3´ diaminobenzidine for 3 minutes as a chromogenic substrate. Sections were counter stained with Harris's hematoxylin, followed by dehydration and mounting.
Normal breast tissue was used as a positive control, according to Pfister et al.'s study. 23 Primary antibodies were substituted with commercially available control reagents as negative con trols, according to the manufacturer's instructions. IHC scoring was performed essentially as described by Brabletz et al. 24 Brief ly, all individual sections were scored for intensity (0, no stain ing; 1, weak; 2, intermediate; 3, strong).
Statistical analysis
The expression levels of hMOF and acetylH4K16 proteins were categorized into twotier groups (low, including scores of 0 and 1 vs high, including scores of 2 and 3), and statistical anal yses were performed using Pearson's chisquare test to analyze the associations among multiple clinical variables. A survival analysis was performed with the KaplanMeier method, and the resulting curves were compared using the logrank test. A mul tivariate analysis was performed using the Cox proportional haz ards model. The results were considered statistically significant at pvalues <0.05. All statistical analyses were performed using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Patients demographics
The patients included 412 (74.8%) males and 139 (25.2%) females with a mean age of 59.3 years. Tumors were histologi cally classified into 242 (43.9%) squamous cell carcinomas and 223 (40.5%) adenocarcinomas. Among the 551 cases, 79 (14.3%) patients had welldifferentiated, 254 (46.1%) moderately dif ferentiated, and 113 (20.5%) poorly differentiated tumors. Lym ph node metastasis was identified in 206 (37.4%) patients at the time of surgery. Lymph node metastasis showed a strong as sociation with NSCLC recurrence (p=0.002). Followup data were available for all 551 patients. Among these, 215 (39.0%) patients developed disease recurrence, including 26 (4.5%) lo coregional recurrences and 215 (39.0%) distant metastases dur ing the followup period.
hMOF mRNA is frequently overexpressed in NSCLC tissues compared with adjacent normal lung tissues and lung cancer cell lines hMOF mRNA level was quantitatively measured in paired freshfrozen lung cancer and normal samples using RQPCR. Ten of 20 (50%) NSCLC tissues revealed hMOF mRNA over expression, compared with normal tissues (Fig. 1) .
hMOF mRNA was overexpressed in two (adenocarcinoma, 54265; squamous cell carcinoma, 52345) of three primary cul ture cell lines (67%) and three of five lung cancer cell lines (60%) (A549, EKVX, and H460) (Fig. 2) . The hMOF mRNA level was eight times higher in 54265 compared to that in normal lung fibroblasts.
Knockdown of hMOF mRNA using siRNA significantly inhibits the growth rate of Calu-6 cells To determine whether hMOF is an effective therapeutic target for NSCLC, the effects of transfected siRNA on hMOF mRNA overexpression in Calu6 cells were measured using RQPCR. Treatment of Calu6 cells with siRNA (10 nM) for 24, 48, and 72hours resulted in effective hMOF knockdown (Fig. 3) . The hMOF mRNA levels relative to those in mocktransfected con trols from independent transfection experiments are presented.
Cell morphology analyses demonstrated that transfection of 10 nM siRNA for 6 days led to significantly inhibited growth in Calu6 cells, compared to mocktransfected cells and scram bled siRNA controls (Fig. 4) . Immunohistochemical staining shows frequent hMOF overexpression in NSCLC tissues and is correlated with histone acetylation
To assess the distribution of cases according to hMOF and acetylated H4K16 staining intensities, frequencies (yaxis, %) were plotted in relation to the categorized scores. In total, 91 (16.5%) of the 551 cases were negative for hMOF. Among the remaining cases, 189 (34.3%) were weakly positive, 138 (25.0%) were intermediately positive, and 81 (14.7%) were strongly positive for hMOF immunostaining (Fig. 5 ). Data were lost for 52 of the 551 cases (9.4%). Additionally, 158 (28.7%) of the 551 cases were negative, 193 (35.0%) were weakly positive, 90 (16.3%) were intermediately positive, and 63 (11.4%) were strongly positive for H4K16Ac immunostaining (Fig. 6) . Simi lar positive staining patterns were obtained with both antibod ies, with 14.7% and 11.4% of the cases showing a score of 3. In contrast, 50.8% and 63.7% of cases were scored "0" or "1" for hMOF and acetylated H4K16, respectively. Our results indi cate that the hMOF and acetylated H4K16 distribution pat terns were similar and closely linked to each other (r=0.062, p<0.0010) ( Table 1) .
Correlation between immunostaining for the hMOF antibody and the clinicopathological variables
The relationships between hMOF expression and clinical pa rameters, including gender, age, size, histological type, histo logical grade, lymph node metastasis, stage, lymphovascular in vasion, recurrence, local recurrence, and distant metastasis were analyzed. Interestingly, hMOF was more strongly expressed in squamous cell carcinomas (p=0.001) and correlated with lym phovascular tumor invasion (p=0.012). However, gender, age, tumor size, lymph node metastasis, stage, and histological grade were not correlated with hMOF expression patterns ( Table 2) . No clinicopathological parameters were significantly associated with acetylated H4K16 immunostaining (data not shown).
hMOF overexpression is associated with good survival in patients with stage III NSCLC as an independent prognostic factor High hMOF expression in the stage III group was associated with longer diseasefree survival (p=0.0025, logrank test) and overall survival (p=0.0016, logrank test) using the Kaplan Meier method (Fig. 7) . Diseasefree median survival times were 71.3 months in the high hMOF expression group and 40.3 mon ths in the low hMOF expression group. Median overall survival times were 75 months in the high group and 42.1 months in the low group. However, no significant differences in survival were evident in the other staged groups. In addition, high hMOF expression in both adjuvant and nonadjuvant groups was not related to survival (adjuvant, p=0.70; nonadjuvant group, p= 0.33).
The multivariate Cox's proportional hazard regression model revealed that the higher hMOF expression group had a better prognosis (p=0.012; hazard ratio, 0.576; 95% confidence in terval, 0.375 to 0.885), suggesting that hMOF is an indepen dent prognostic factor (Table 3) . 
DISCUSSION
This study reports the first comprehensive survey on the ex pression patterns of hMOF and corresponding modified H4 K16Ac in lung tumor tissues. Here, we established the hMOF mRNA level with RQPCR and hMOF and acetylated H4K16 protein expression patterns in a large series of primary NSCLC cases using IHC. In contrast to control sections, hMOF overex pression was observed in a large subset of primary NSCLCs (cell lines, 3/5 [ 60% ] ; fresh frozen lung cancer tissue, 10/20 [ 50% ] ; paraffinembedded NSCLC tissue, 184/489 [ 37.6% ] ). In all tis sues investigated, hMOF expression was significantly correlated with H4K16 acetylation (r=0.062, p<0.001). hMOF overex pression was considerably more frequent in squamous cell carci nomas than that in adenocarcinomas and in the presence of lym phovascular tumor invasion. Patients with stage III NSCLC overexpressing hMOF showed good survival, as evident from the multivariate analysis using the Cox regression model, indi cating its utility as an independent prognostic factor.
Recent studies have reported that hMOF is downregulated in primary breast cancers 23 and medulloblastomas, 23 and that hMOF overexpression is a good prognostic factor for medulloblastoma. Conversely, Gupta et al. 25 suggested that acetylation of histone H4 at K16 by hMOF is an epigenetic signature of cellular pro liferation common to both embryogenesis and oncogenesis, and that MOF is essential for these processes. We observed high lev els of hMOF mRNA and protein in NSCLC compared with nor mal tissue. Moreover, hMOF overexpression was related to a good prognosis in stage III patients. These findings indicate that both downregulation and overexpression of hMOF can lead to carcinogenesis in an organ or tumorspecific manner. Addi tionally, aberration of hMOF function in human cells results in genomic instability, cell cycle defects, chromosomal abnormali ties, and an impaired DNA damage response. 1517 These results collectively support the notion that hMOF plays an important role in NSCLC progression.
Several possible mechanisms linking hMOF expression to can cer could explain these findings. For example, hMOF overexpre ssion and H4K16 acetylation may alter global chromatin struc ture, making it more susceptible to DNA damage 26 or hMOF may play a more direct role in regulating the response to DNA damage. 18 Previous multiple assays to quantitate H4K16 monoacety lation at the global and genome region/locusspecific levels have suggested loss of monoacetylation at H4K16 in tumors and tu morderived cell lines. 13 However, our experiments demonstrat ed similar or higher levels of hMOF or H4K16Ac in tumors and tumorderived cell lines, compared to those of normal con trol cells. Analogous results were obtained with different trans formed cell lines. 25 After examining a large number of tumor derived cell lines and tumor samples, Gupta et al. 25 proposed that hMOF and H4K16Ac are required for both in vitro and in vivo transformation. Interestingly, hMOF overexpression is asso ciated with both increased H4K16 acetylation and cell prolifer ation, 16, 17 whereas cells treated with SIRT1 inhibitors display increased H4K16 acetylation levels but reduced proliferation. 24 Thus, although cell proliferation appears closely related with hMOF, its relationship with H4K16 acetylation status requires further study.
Loss of MOF and H4K16Ac is correlated with increased ge nomic instability, 16, 17 which is an important step in cancer de velopment, as it significantly accelerates the genetic changes leading to tumor cell progression. 27 However, another study showed that genomic instability and increased radiosensitivity caused by depletion of hMOF leads to decreased oncogenic trans formation, whereas its overexpression results in increased onco genic transformation, 25 suggesting that the loss of hMOF is not a marker of oncogenesis. The role of hMOF in cellular prolifera tion is supported by the finding that its overexpression results in enhanced oncogenic transformation and faster relapse of tu mor growth after radiation treatment. 25 Clearly, hMOF expres sion and H4K16 acetylation are linked with proliferation sta tus. These novel data provide a foundation for the molecular significance of epigenetic modifications in varied contexts of embryonic development, tumorigenesis, and DNA metabolism.
The concept of antisense oligodeoxynucleotides as modula tors of gene expression and their application in targeted cancer gene therapy was developed more than 25 years ago. 28 Preclini cal studies have confirmed that RNAi techniques can be applied to silence cancerrelated targets. 29 In vivo studies have also shown favorable outcomes of targeting RNAi components critical for tumor cell growth, metastasis, angiogenesis, and chemoresis tance. 30 In the current investigation, growth inhibition of tu mor cells was induced by hMOF gene knockdown using siR NA, supporting its utility as a candidate therapeutic target.
The Calu6 cell line was employed in the present study to confirm the knockdown effect of RNA interference. Calu6, a poorly differentiated metastatic carcinoma cell line, was selected due to its rapid growth, which makes it easier to handle. The hMOF mRNA level in Calu6 cells decreased, compared with that in other NSCLC cell lines (Fig. 2) , and siRNA treatment effectively inhibited cell growth (Fig. 4) . To eliminate the effect of decreased hMOF mRNA level in the Calu6 cell line, addi tional experiments are required with other cell lines that over express hMOF mRNA.
The main limitation of the clinical data analysis was a lack of smoking history. Smoking is the most prevalent cause of squa mous cell carcinoma. Our data showed that hMOF overexpres sion is related to squamous cell carcinoma (Table 2 ). However, we were unable to evaluate whether smoking history was related to hMOF expression. In addition, stage III patients with hMOF overexpression showed good survival. Unfortunately, the stage III patient group was insufficient to predict a prognosis, and the patient population may not have been homogeneous. Larger po pulations with a longterm followup are required to effectively develop a prognosis.
There are additionally some drawbacks for clarifying hMOF function based on an analysis of protein levels by Western blot. We expected to detect hMOF protein in tissues displaying acet ylated H4K16. However, only one tissue sample expressed hM OF concordant with acetylated H4K16. This discrepancy may be attributed to degradation of hMOF during tissue preparation or the possibility that hMOF mRNA does not directly function as a protein due to unknown reasons.
In conclusion, the histone acetyltransferase hMOF was fre quently overexpressed in NSCLC at the mRNA level. Tumor cell growth was effectively inhibited by knockdown of the gene using siRNA. The results suggest that hMOF is a type of onco gene and a candidate therapeutic target of NSCLC. The current study on hMOFrelated oncogenesis in patients with NSCLC provides preliminary data that should aid in elucidating the fun damental mechanisms of cancer biology.
